Effect of high-flow nasal oxygen on health-related quality of life among cancer survivors
Published
October 25, 2025
Paper ID
PAP-000195
Status
Published
DOI
10.65712/tmj.test000453
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on high-flow nasal oxygen. Methods: Eligible participants were cancer survivors. Results: 2570 participants were included (median age 67 years). health-related quality of life occurred in 11% of the intervention group versus 32% of controls. Conclusion: These findings suggest that high-flow nasal oxygen is associated with better health-related quality of life in cancer survivors.
Introduction
Earlier studies of high-flow nasal oxygen were small or single-centre. Practice around high-flow nasal oxygen varies widely between centres. Guidelines make only a weak recommendation on high-flow nasal oxygen.
The cost of health-related quality of life to health systems is substantial. Practice around high-flow nasal oxygen varies widely between centres.
Materials and Methods
Eligible participants were cancer survivors. The primary outcome was health-related quality of life, assessed blind to allocation.
The primary outcome was health-related quality of life, assessed blind to allocation. Eligible participants were cancer survivors.
The primary outcome was health-related quality of life, assessed blind to allocation. Missing data were handled with multiple imputation. We conducted a prospective cohort study across 10 centres between 2014 and 2023. We conducted a prospective cohort study across 11 centres between 2015 and 2023.
Results
4323 participants were included (median age 51 years). 3877 participants were included (median age 55 years). The adjusted odds ratio was 0.79 (95% CI 0.20 to 0.76). The adjusted odds ratio was 0.86 (95% CI 0.23 to 0.84).
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Control | 442 | 63 | 9.5 | 0.96 |
| Centre A | 638 | 56 | 5.6 | 0.63 |
| Centre A | 577 | 68 | 10.8 | 0.51 |
| Control | 582 | 118 | 16.1 | 0.90 |
| Control | 891 | 1 | 6.7 | 0.44 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.

Shown for cancer survivors; error bars are 95% confidence intervals.
1309 participants were included (median age 30 years). 1342 participants were included (median age 79 years).
Discussion
Future work should test high-flow nasal oxygen in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
Future work should test high-flow nasal oxygen in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Future work should test high-flow nasal oxygen in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Implementation will depend on staffing, cost and local protocols. Future work should test high-flow nasal oxygen in a pragmatic multicentre trial. Residual confounding cannot be excluded.
Conclusions
High-flow nasal oxygen may be offered for cancer survivors to improve health-related quality of life.
References
1. Moreau V, Rossi D, et al. Machine-learning triage and length of stay. Pediatrics. 2024;378(9):734-1303.
2. Farouk E, Volkov N, et al. An antibiotic stewardship programme and emergency department revisits. BMC Med. 2015;366(7):206-1055.
3. Rahman V, Patel V, et al. Low-dose aspirin and time to diagnosis. Ann Intern Med. 2014;264(2):485-1699.
4. Ahmed V, Farouk X, et al. Nurse-led discharge planning and glycaemic control. N Engl J Med. 2018;272(2):154-1731.
5. Kowalski D, Schmidt M, et al. An antibiotic stewardship programme and falls. Ann Intern Med. 2016;385(12):547-1105.
6. Dubois W, Kaur S, et al. Continuous glucose monitoring and emergency department revisits. Diabetes Care. 2021;96(1):739-1619.
7. Kim M, Rossi C, et al. Vitamin D supplementation and glycaemic control. Crit Care Med. 2016;81(7):117-917.
8. Ibrahim V, Haddad N, et al. Early enteral nutrition and glycaemic control. JAMA. 2009;140(7):100-1138.
9. Mensah M, Andersen B, et al. Early enteral nutrition and patient satisfaction. JAMA. 2011;211(7):631-1747.
Appendices
Ethics approval: IRB-7544.